– New genetic testing initiative designed to enable improved patient diagnosis of ALSP, a devastating, rare genetic neurodegenerative disease – – Through ALSPAware, individuals and. | May 8, 2023
Today, the U.S. Senate passed the FDA Modernization Act 2.0, S.5002, without dissent, taking a major step toward enacting a policy that could dramatically